FDA Consumer

View more issues:

Articles in July-August, 2003 issue of FDA Consumer

• Improving product safety through data mining
• Study: tight glucose control in diabetes lowers risk of atherosclerosis
• FDA bioterrorism Web site widens its scope
  by John Henkel
• New drug helps relieve chemotherapy-related symptoms
• GERD implant approved
• FDA works to reduce preventable medical device injuries
  by Carol Rados
• Treatment for growth hormone disorder
• New guidelines set lower mark for high blood pressure
• Need to talk about health? Try a hot line
  by John Henkel
• Recall of counterfeit Lipitor
• Rapid test for Aspergillus infection
• Hispanic health: renewed collaboration
  by Linda Bren
• Expanded use of brain implant
• Joint FDA, NCI program aims to streamline cancer drug development
• How to lower your cholesterol levels
  by John Henkel
• Breath test monitors asthma
• FDA approves Gleevec for pediatric leukemia
• Alzheimer's searching for a cure
  by Linda Bren
• The 'hidden' victims of Alzheimer's disease
  by Terry Ullman
• New regimen for kidney transplants
• Labeling changes for cholesterol drug
• Speedy approvals for new cancer treatments
• First treatment for Fabry's disease
• FDA statement on ensuring 'safe food'
• FDA, Red Cross reach agreement to improve blood safety
  by Carol Rados
• Observations
  by Ray Jr. Formanek
• First treatment for rare enzyme disorder
• FDA's response to food, dietary supplement, and cosmetic adverse events
  by Linda Bren
• A 'scrapbook' for teen consumers—by Teen Consumers
  by John Henkel
• 'Poison' versus `English' ivy
  by Wade Shuford
• New drug-device combination helps keep arteries open
• SARS protecting against a deadly disease
  by Carol Rados
• Colorado couple caught defrauding drug companies
  by Michelle Meadows